Table 2. Treatment in women with ST group and non-ST group.
| ST group(N = 22) | Non-ST group(N = 39) | p-value | |
| Treatment during pregnancy, n | |||
| Steroid | 2 (9.1%) | 1 (2.6%) | 0.173 |
| Transfusion | 16 (72.7%) | 6 (15.4%) | <0.001 |
| Immunsuppressive therapy | 1 (4.5%) | 0 (0.0%) | 0.179 |
| Packed RBCa | 4.84±6.6 | 0.40±0.96 | <0.001 |
| PCa | 9.00±19.0 | 0.19±1.23 | 0.004 |
| SDPa | 1.63±4.04 | 0.02±0.15 | 0.012 |
| Treatment during labor | |||
| ransfusion | 20 (90.9%) | 28 (71.8%) | 0.080 |
| Packed RBCa | 3.11±2.78 | 1.43±1.97 | 0.010 |
| PCa | 16.4±28.3 | 4.67±7.851 | 0.015 |
| SDPa | 0.78±1.114 | 0.55±1.292 | 0.513 |
| FFPa | 0.11±0.459 | 0.00±0.00 | 0.138 |
| Treatment after delivery | |||
| Steroid | 2 (10.0%) | 4 (10.8%) | 0.924 |
| Transfusion | 9 (45.0%) | 1 (2.7%) | <0.001 |
| BMT | 5 (25.0%) | 0 (0.0%) | <0.001 |
| Immunsuppressive therapy | 3 (15.0%) | 1 (2.7%) | 0.083 |
| Packed RBCa | 0.62±1.586 | 0.00±0.00 | 0.016 |
| SDPa | 0.81±1.47 | 0.03±0.16 | 0.002 |
AA, aplastic anemia; ST, severe thrombocytopenia; CR, complete remission; PR, partial remission, NR, no response, RBC, red blood cell; PC, platelet concentrate; SDP, single donor platelet; FFP, fresh frozen plasma; BMT, bone marrow transplant.
Data are presented as the median (range) or number (percentage) of patients.
a
Data are presented as mean ± SD.